h-FABP
h-FABP has the highest content in cardiomyocytes, but very little in other tissues, and the specificity of cardiomyocytes is strong. After myocardial injury, it can be quickly released into the blood, and its concentration can be detected in the serum at the earliest half hour. It is an ideal marker to reflect myocardial injury.
| Description | Type | Item No | Source | Use for | Application |
| h-FABP Antigen | rAg | GHCA081-1 | E.coli | Quality Control | ELISA,CLIA,LFT |
| h-FABP-B11 | mAb | GHMA090-1 | mouse | Coating | ELISA,CLIA,LFT |
| h-FABP-2F9 | mAb | GHMA090-2 | mouse | Labeling | ELISA,CLIA,LFT |
NT-proBNP
NT-proBNP is the best myocardial marker for the diagnosis of chronic heart failure and the prevalence of chronic heart failure and acute myocardial infarction.At present, it is the only biochemical index that can be used to evaluate cardiac diastolic function.
| Description | Type | Item No | Source | Use for | Application |
| NT-proBNP Antigen | rAg | GHCA073-1 | E.coli | Quality Control | ELISA,CLIA,LFT |
| NT-proBNP-21G6 | mAb | GHMA050-1 | mouse | Coating | ELISA,CLIA,LFT |
| NT-proBNP-4D1 | mAb | GHMA050-2 | mouse | Labeling | ELISA,CLIA,LFT |
MYO
In acute myocardial injury, MYO is released into the bloodstream and may exceed the normal upper limit about 2-3 hours after symptom onset, peaking 9-12 hours before returning to normal 24-36 hours later. Determination of serum myoglobin can be used as the most sensitive index for early diagnosis of acute myocardial infarction (AMI).
| Description | Type | Item No | Source | Use for | Application |
| MYO Antigen | rAg | GHCA068-1 | E.coli | Quality Control | ELISA,CLIA,LFT |
| MYO-12E3 | mAb | GHMA029-1 | mouse | Coating | ELISA,CLIA,LFT |
| MYO-5G4 | mAb | GHMA029-2 | mouse | Labeling | ELISA,CLIA,LFT |
| MYO-8E3 | mAb | GHMA029-3 | mouse | Labeling | ELISA,CLIA,LFT |
cTnI
cTnl only exists in atrial muscle and ventricular muscle, so it has high specificity. Cardiac cTnl has high sensitivity and specificity in reflecting myocardial injury, especially when it is more sensitive than traditional myocardial enzymes for minor myocardial injury and sustained injury.
| Description | Type | Item No | Source | Use for | Application |
| cTnI Antigen | rAg | GHCA072-1 | E.coli | Quality Control | ELISA,CLIA,LFT |
| cTnI-15C6 | mAb | GHMA020 | mouse | Coating | ELISA,CLIA,LFT |
| cTnI-8D3 | mAb | GHMA021 | mouse | Labeling | ELISA,CLIA,LFT |
D-dimer
D-dimer test is often used to diagnose disseminated intravascular coagulation (DIC), deep vein thrombosis (DVT), pulmonary embolism, myocardial infarction and cerebral infarction. This index can be used not only for the diagnosis of thrombotic diseases, but also for the dose monitoring and efficacy observation of thrombolytic drugs.
| Description | Type | Item No | Source | Use for | Application |
| D-Dimer-1A4 | mAb | GHMA096-1 | mouse | Labeling/Coating | ELISA,CLIA,LFT |
| D-Dimer-4E6 | mAb | GHMA096-2 | mouse | Labeling/Coating | ELISA,CLIA,LFT |
MPO
MPO can not only identify unstable plaques at early stage, which is one of the inflammatory markers for the early diagnosis of acute coronary syndrome, but also predict the future risk of cardiovascular disease independently, instead of relaying on C-reactive protein and other inflammatory markers.
| Description | Type | Item No | Source | Use for | Application |
| MPO-2A7 | mAb | GHMA059-1 | mouse | Labeling | ELISA,CLIA,LFT |
| MPO-2E9 | mAb | GHMA059-2 | mouse | Coating | ELISA,CLIA,LFT |